Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:217399G60.8
Who is this for?
Show terms as
1FDA treatments8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital insensitivity to pain with hyperhidrosis and absence of cutaneous sensory innervation is an extremely rare hereditary sensory and autonomic neuropathy (HSAN) characterized by a complete inability to perceive pain from birth, excessive sweating (hyperhidrosis), and a documented absence of sensory nerve fibers in the skin. This condition is classified among the hereditary sensory and autonomic neuropathies and is sometimes considered a distinct subtype within the HSAN spectrum. It primarily affects the peripheral nervous system, specifically the small unmyelinated and thinly myelinated sensory nerve fibers responsible for pain and temperature sensation in the skin. Patients typically present in infancy or early childhood with painless injuries, including burns, fractures, and self-mutilation injuries to the tongue, lips, and fingers, due to the complete absence of protective pain sensation. Hyperhidrosis (excessive sweating) distinguishes this condition from some other forms of congenital insensitivity to pain. Skin biopsy reveals a striking absence of cutaneous sensory innervation, confirming the peripheral nerve fiber deficit. Other sensory modalities such as touch and proprioception may be variably affected. Intellectual development is generally normal. There is currently no curative treatment for this condition. Management is supportive and focuses on injury prevention, careful monitoring of the skin and extremities, dental care to prevent self-inflicted oral injuries, orthopedic surveillance for unrecognized fractures, and education of patients and caregivers about the risks associated with the inability to feel pain. Treatment of hyperhidrosis may also be addressed symptomatically. A multidisciplinary approach involving neurology, orthopedics, dermatology, and pain management specialists is recommended.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Feb 2010

Cayston: FDA approved

To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Cayston

aztreonam· Gilead Sciences, Inc.Orphan Drug

To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa

No actively recruiting trials found for Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation community →

No specialists are currently listed for Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Cayston(aztreonam)Gilead Sciences, Inc.

Travel Grants

No travel grants are currently matched to Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervationForum →

No community posts yet. Be the first to share your experience with Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation.

Start the conversation →

Latest news about Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation

No recent news articles for Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation

What is Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation?

Congenital insensitivity to pain with hyperhidrosis and absence of cutaneous sensory innervation is an extremely rare hereditary sensory and autonomic neuropathy (HSAN) characterized by a complete inability to perceive pain from birth, excessive sweating (hyperhidrosis), and a documented absence of sensory nerve fibers in the skin. This condition is classified among the hereditary sensory and autonomic neuropathies and is sometimes considered a distinct subtype within the HSAN spectrum. It primarily affects the peripheral nervous system, specifically the small unmyelinated and thinly myelinate

How is Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation inherited?

Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation typically begin?

Typical onset of Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation?

1 patient support program are currently tracked on UniteRare for Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation. See the treatments and support programs sections for copay assistance, eligibility, and contact details.